Insulin glargine

Details

Files

Generic Name:

Insulin glargine (rDNA origin)

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus, Type 1 & 2

Manufacturer:

Sanofi-Aventis Canada Inc.

Brand Name:

Lantus

Project Line:

Reimbursement Review

Project Number:

SF0166-000

Submission Type:

Request For Advice

Indications:

Diabetes mellitus, Type 1 & 2

Recommendation Type:

N/A

Files

Submission Status Report View PDF

Last Updated : June 9, 2009